טוען...
Epigenetic Reexpression of Hemoglobin F Using Reversible LSD1 Inhibitors: Potential Therapies for Sickle Cell Disease
[Image: see text] Sickle cell disease (SCD) is caused by a single nucleotide polymorphism on chromosome 11 in the β-globin gene. The resulting mutant hemoglobin S (HbS) is a poor oxygen transporter and causes a variety of vascular symptoms and organ failures. At birth, the DRED epigenetic complex fo...
שמור ב:
| הוצא לאור ב: | ACS Omega |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Chemical Society
2020
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7315572/ https://ncbi.nlm.nih.gov/pubmed/32596612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.0c01585 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|